Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]:
SEC Accession No. 0001279569-14-001677
Filing Date
2014-10-20
Accepted
2014-10-20 16:50:54
Documents
8
Effectiveness Date
2014-10-20

Document Format Files

Seq Description Document Type Size
1 SUPPL v391646_suppl.htm SUPPL 439324
2 GRAPHIC image_002.gif GRAPHIC 6411
3 GRAPHIC image_002.jpg GRAPHIC 17961
4 GRAPHIC image_003.jpg GRAPHIC 15398
5 GRAPHIC tpg1.jpg GRAPHIC 10371
6 GRAPHIC tpg13.jpg GRAPHIC 47153
7 GRAPHIC tpg14.jpg GRAPHIC 50700
8 GRAPHIC tpg8.jpg GRAPHIC 68820
  Complete submission text file 0001279569-14-001677.txt   739995
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SUPPL | Act: 98 | File No.: 333-197633 | Film No.: 141164316
SIC: 2834 Pharmaceutical Preparations